Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (12): 69-76.doi: 10.6040/j.issn.1671-7554.0.2022.0495

Previous Articles     Next Articles

Analysis of 5-year survival rate and prognosis in 188 children with systemic lupus erythematosus

KONG Linxiaoyu1,2, SUN Shuzhen1,2, YU Lichun1,2, JIA Mengwen1,2   

  1. 1. Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China;
    2. Department of Pediatrics, Shandong Provincial Hospital Affiliated to Shandong Frist Medical University, Jinan 250021, Shandong, China
  • Published:2022-12-01

Abstract: Objective To summarize the clinical characteristics of childhood-onset systemic lupus erythematosus(cSLE), analyze the 5-year survival rate, causes of relapse and death, and factors affecting prognosis, in order to provide a basis for improving the prognosis and guiding the treatment. Methods Clinical data of 188 SLE patients treated during Jan. 1, 2009 and Dec. 31, 2020 were retrospectively collected and the patients were followed up in clinic or with telephone. The survival rate was analyzed using Kaplan-Meier method, and the prognostic factors were analyzed using Log-rank test and cox parametric regression analysis. Results Of the 188 children, 40 were male and 148 were female, mean age of onset were(10.64±2.12)years, median duration of illness from onset to diagnosis were 30(15, 60)days. The most common clinical manifestations were fever and rash. Renal damage and hematologic damage were often observed at diagnosis. During the follow-up, 73 children(38.8%)had relapse, mainly due to poor compliance and infection; 16 children died, mainly due to poor compliance, multiple organ damage, infection, and renal insufficiency. The 1-year, 3-year and 5-year survival rates were 94.1%, 92.9%, and 91.7%, respectively. Univariate analysis showed that cardiovascular system damage(χ2=4.464, P=0.035), neurological system damage(χ2=6.545, P=0.011), hematological system damage(χ2=3.888, P=0.049), massive proteinuria(χ2=5.641, P=0.018), severe activity of the initial disease(χ2=4.679, P=0.031), induction therapy disease inactivity(χ2=7.561, P=0.006), and relapse(χ2=13.786, P≤0.001)were associated with prognosis. Cox parametric regression analysis showed that cardiovascular system damage(HR=3.361, 95%CI: 1.251-9.029, P=0.016), neurological damage(HR=2.997, 95%CI: 1.076-8.349, P=0.036), massive proteinuria(HR=2.162, 95%CI: 1.079-4.334, P=0.030), and relapse(HR=4.663, 95%CI: 1.666-13.049, P=0.003)were independent risk factors of poor prognosis. Conclusion The main clinical manifestations of SLE are fever and rash, and systemic damages are renal damage and hematologic damage. The overall 5-year prognosis for patients complicated with cardiovascular damage, neurological damage, massive proteinuria and with recurrence is poor. Active control of organ damage, timely reduction of proteinuria, and prevention of recurrence are key to improving survival.

Key words: Systemic lupus erythematosus, Children, Survival rate, Prognosis

CLC Number: 

  • R725.9
[1] Harry O, Yasin S, Brunner H. Childhood-onset systemic lupus erythematosus: a Review and update [J]. J Pediatr, 2018, 196: 22-30. doi: 10.1016/j.jpeds.2018.01.045.
[2] Trindade VC, Carneiro-Sampaio M, Bonfa E, et al. An update on the management of childhood-onset systemic lupus erythematosus [J]. Paediatr Drugs, 2021, 23(4): 331-347.
[3] Mina R, Brunner HI. Pediatric lupus-are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? [J]. Rheum Dis Clin North Am, 2010, 36(1): 53-80.
[4] Moghaddam B, Marozoff S, Li L, et al. All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study [J]. Rheumatology(Oxford), 2021, 61(1): 367-376.
[5] Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [J]. Arthritis Rheum, 1997, 40(9): 1725.
[6] Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus [J]. Arthritis Rheum, 2012, 64(8): 2677-2686.
[7] 范晖, 闫银坤, 米杰. 中国3~17岁儿童性别、年龄别和身高别血压参照标准[J]. 中华高血压杂志, 2017, 25(5): 428-435. FAN Hui, YAN Yinkun, MI Jie. Updating blood pressure references for Chinese children aged 3-17 years [J]. Chinese Journal of Hypertension, 2017, 25(5): 428-435.
[8] Weening JJ, DAgati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited [J]. J Am Soc Nephrol, 2004, 15(2): 241-250.
[9] 全国儿童风湿病协作组. 儿童风湿病诊断及治疗专家共识(二)[J]. 临床儿科杂志, 2010, 28(11): 1089-1094. National Childrens Rheumatic Disease Collaboration Group. Diagnosis and treatment of pediatric rheumatic diseases: a consensus statement [J]. Journal of Clinical Pediatrics, 2010, 28(11): 1089-1094.
[10] 宋红梅. 儿童系统性红斑狼疮诊疗建议解读[J]. 中华儿科杂志, 2011, 49(7): 515-518. SONG Hongmei. The explanation of SGI-PS-CMA evidence-based recommendations for the diagnosis and management of juvenile systemic lupus erythematosus [J]. Chinese Journal of Pediatrics, 2011, 49(7): 515-518.
[11] 党西强, 易著文. 狼疮性肾炎诊治循证指南(2016)解读[J]. 中华儿科杂志, 2018, 56(2): 95-99. DANG Xiqiang, YI Zhuwen. Interpretation of evidence-based guideline on diagnosis and treatment of lupus nephritis(2016)[J]. Chinese Journal of Pediatrics, 2018, 56(2): 95-99.
[12] Wei Q, Wang W, Dong Y, et al. Five years follow-up of juvenile lupus nephritis: a single-center retrospective cohort study [J]. Ann Palliat Med, 2021, 10(7): 7351-7359.
[13] Ceccarelli F, Perricone C, Cipriano E, et al. Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment [J]. Semin Arthritis Rheum, 2017, 47(1): 53-64.
[14] Groot N, Shaikhani D, Teng YKO, et al. Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus [J]. Arthritis Rheumatol, 2019, 71(2): 290-301.
[15] Rodsaward P, Prueksrisakul T, Deekajorndech T, et al. Oral ulcers in juvenile-onset systemic lupus erythematosus: a review of the literature [J]. Am J Clin Dermatol, 2017, 18(6): 755-762.
[16] Joo YB, Park SY, Won S, et al. Differences in clinical features and mortality between childhood-onset and adult-onset systemic lupus erythematosus: a prospective single-center study [J]. J Rheumatol, 2016, 43(8): 1490-1497.
[17] 李正芳, 吴雪, 罗采南, 等. 系统性红斑狼疮五年生存率及影响预后的因素[J]. 新疆医学, 2021, 51(11): 1229-1231. LI Zhengfang, WU Xue, LUO Cainan, et al. Analysis of 5-year survival rate and prognostic indicators of systemic lupus erythematosus [J]. Journal of Management, 2021, 51(11): 1229-1231.
[18] Tucker LB, Uribe AG, Fernández M, et al. Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort(LUMINA LVII)[J]. Lupus, 2008, 17(4): 314-322.
[19] Watson L, Leone V, Pilkington C, et al. Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort [J]. Arthritis Rheum, 2012, 64(7): 2356-2365.
[20] Ravelli A, Ruperto N, Martini A. Outcome in juvenile onset systemic lupus erythematosus [J]. Curr Opin Rheumatol, 2005, 17(5): 568-573.
[21] Lee PY, Yeh KW, Yao TC, et al. The outcome of patients with renal involvement in pediatric-onset systemic lupus erythematosus: a 20-year experience in Asia [J]. Lupus, 2013, 22(14): 1534-1540.
[22] Wong SN, Tse KC, Lee TL, et al. Lupus nephritis in Chinese children - a territory-wide cohort study in Hong Kong [J]. Pediatr Ne-phrol, 2006, 21(8): 1104-1112.
[23] Fatemi A, Matinfar M, Smiley A. Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality [J]. Clin Rheumatol, 2017, 36(2): 343-350.
[24] Tektonidou MG, Lewandowski LB, Hu J, et al. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016 [J]. Ann Rheum Dis, 2017, 76(12): 2009-2016.
[25] 程程, 文思佳, 林知朗, 等. 儿童狼疮性肾炎的疗效及预后分析[J]. 中华儿科杂志, 2021, 59(9): 730-736. CHENG Cheng, WEN Sijia, LIN Zhilang, et al. Treatment effectiveness and long-term prognosis of childhood-onset lupus nephritis[J]. Chinese Journal of Pediatrics, 2021, 59(9): 730-736.
[26] Davidson JE, Fu Q, Ji B, et al. Renal remission status and longterm renal survival in patients with lupus nephritis: a retrospective cohort analysis[J]. J Rheumatol, 2018, 45(5): 671-677.
[27] Govoni M, Bortoluzzi A, Padovan M, et al. The diagnosis and clinical management of the neuropsychiatric manifestations of lupus [J]. J Autoimmun, 2016, 74: 41-72. doi: 10.1016/j.jaut.2016.06.013.
[28] Monahan RC, Fronczek R, Eikenboom J, et al. Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: a retrospective analysis from a tertiary referral center in the Netherlands [J]. Lupus, 2020, 29(14): 1892-1901.
[29] Williams FM, Chinn S, Hughes GR, et al. Critical illness in systemic lupus erythemato-sus and the antiphospholipid syndrome [J]. Ann Rheum Dis, 2002, 61(5): 414-421.
[30] Chen J, Tang Y, Zhu M, et al. Heart involvement in systemic lupus erythematosus: a systemic review and meta-analysis [J]. Clin Rheumatol, 2016, 35(10): 2437-2448.
[31] 何晓蕾, 徐清, 王伦文. 系统性红斑狼疮并发心血管疾病的临床研究[J]. 临床心血管病杂志, 2013, 29(8): 633-634. HE Xiaolei, XU Qing, WANG Lunwen. Clinical study of systemic lupus erythematosus patients with cardiovascular disease [J]. Journal of Clinical Cardiology, 2013, 29(8): 633-634.
[32] 张培敏, 樊蓉, 李想, 等. 泼尼松联合霉酚酸酯对比环磷酰胺治疗狼疮性肾炎的系统评价[J]. 实用药物与临床, 2015, 18(2): 130-135. ZHANG Peimin, FAN Rong, LI Xing, et al. Mycophenolate mofetil versus cyclophospha-mide combined with prednisone in induction therapy for lupus nephritis: a systematic review [J]. Practical Pharmacy and Clinical Remedies, 2015, 18(2): 130-135.
[33] Jin SY, Huang DL, Dang XQ, et al. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies [J]. Paediatr Int Child Heal, 2017, 37(4): 286-291.
[34] 黄建萍, 都娟. 儿童系统性红斑狼疮复发与持续不缓解[J]. 中国实用儿科杂志,2012, 27(9): 657-659.
[35] Lopes SRM, Gormezano NWS, Gomes RC, et al. Outcomes of 847 childhood-onset systemic lupus erythematosus patients in three age groups [J]. Lupus, 2017, 26(9): 996-1001.
[1] YANG Jing, ZHANG Lei. Early childhood multi-niche viromes: unclassified phage diversity and host features [J]. Journal of Shandong University (Health Sciences), 2026, 64(5): 116-124.
[2] SUN Honglin, GUAN Yuqiang, YU Peiru, LI Lei, DU Qingxia, DING Hao. Feasibility and short-to-medium-term efficacy of stent implantation for the treatment of aortic coarctation complicated by hypertension in children [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 58-62.
[3] KUANG Li, XU Heyan. From precision assessment to integrated intervention: innovations and future perspectives in the diagnostic and therapeutic paradigm for child and adolescent mental health disorders [J]. Journal of Shandong University (Health Sciences), 2026, 64(3): 10-16.
[4] LI Fanghua, LIU Na, LI Xiaoyu, XU Dianhua, WANG Qian. Research progress on medication adherence in children and adolescents with depressive disorder [J]. Journal of Shandong University (Health Sciences), 2026, 64(3): 24-34.
[5] SUN Jiali, WANG Liang, WANG Changfeng, ZHANG Jie, GUO Lei. Emotional and behavioral problems in children with Klippel-Trenaunay syndrome: characteristics and influencing factors [J]. Journal of Shandong University (Health Sciences), 2026, 64(3): 78-82.
[6] WANG Qian, HU Xiaojing, WANG Aiqing, SUN Qiang, MENG Chunyan, LI Fanghua. Visual analysis of non-suicidal self-injury literature about children and adolescents with depressive disorder [J]. Journal of Shandong University (Health Sciences), 2026, 64(3): 93-107.
[7] WANG Yueqi, SONG Dongyu, LI Yuli, XIE Hao, ZHANG Yuerong. Mediating role of childrens difficulties and prosocial behaviour in the relationship between family resilience and grandparenting stress [J]. Journal of Shandong University (Health Sciences), 2026, 64(1): 57-64.
[8] LI Ziqi, WEI Yanruoxue, LIU Xiaohan, LIU Chuncheng, ZHAO Ran, LIU Yukun. The functional role and clinical significance of lncRNA HEATR3-AS1 in colorectal cancer tumorigenesis and progression [J]. Journal of Shandong University (Health Sciences), 2025, 63(9): 108-115.
[9] LIU Baoguo, SONG Xiang, ZHAO Xiaowen, MAO Yali. Application value of serum STAT5B and NKAIN1 mRNA detection in breast cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 68-74.
[10] CAO Luofei, WANG Shanshan, WANG Jinrong, JIANG Heyun, MIAO Yu, MA Guangzeng. Analysis of the characteristics of bronchial dilation test in children with FeNO elevation during asthma exacerbation [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 38-44.
[11] WANG Lei, CHANG Xiao, WANG Zimeng, LI Jiaojiao, CUI Shujun, YANG Fei, ZHU Yuexiang. Predictive value of intratumoral and peritumoral DCE-MRI imaging histology for progression-free survival in patients with cervical cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 45-54.
[12] JIA Ruoxi, LYU Li, LIU Hanyun, WU Yinping, LI Fengcai, ZHAO Zehua, WANG Kai, FAN Yuchen. Diagnostic value of blood cell count-related biomarkers in predicting 28-day mortality in acute-on-chronic hepatitis b liver failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 89-99.
[13] CHEN Xujun, HE Guowei. Focus on further more use of arterial grafts in coronary artery bypass grafting in patients with coronary heart disease in China [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 1-5.
[14] MO Xuming, WANG Qingfeng. Application of coronary artery bypass grafting in pediatric cardiovascular disease [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 40-46.
[15] LI Ling, YAN Yuhan, KONG Qingyu, WANG Minmin, ZHAO Haizhao, ZHAO Cuifen. Correlation between orthostatic intolerance symptom scores, catecholamine and emotional disorders in children with vasovagal syncope [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 71-78.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!